William Paul Esler

Title: William Paul Esler: Innovator in Pharmaceutical Treatments

Introduction

William Paul Esler is a notable inventor based in Clinton, CT (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of liver diseases. With a total of 3 patents to his name, Esler's work is focused on innovative therapeutic methods.

Latest Patents

Esler's latest patents include groundbreaking methods for treating non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). One of his patents describes a method for treating fatty liver disease using a composition that includes a specific amount of (S)-2-(5-((3-ethoxypyridin-2-yl)oxy)pyridin-3-yl)-N-(tetrahydrofuran-3-yl)pyrimidine-5-carboxamide and a pharmaceutically acceptable salt thereof. Another patent outlines a combination treatment for NASH, utilizing the same compound along with 4-(4-(1-Isopropyl-7-oxo-1,4,6,7-tetrahydrospiro[indazole-5,4'-piperidine]-1′-carbonyl)-6-methoxypyridin-2-yl)benzoic acid or its pharmaceutically acceptable salt.

Career Highlights

Esler is currently employed at Pfizer Corporation, where he continues to develop innovative treatments. His work has been instrumental in advancing therapeutic options for patients suffering from liver diseases.

Collaborations

Esler collaborates with talented professionals in his field, including Trenton Thomas Ross and Neeta Balkrishan Amin. Their combined expertise contributes to the success of their projects and the development of effective treatments.

Conclusion

William Paul Esler is a distinguished inventor whose work in pharmaceutical treatments has the potential to significantly impact the lives of those affected by liver diseases. His innovative patents and collaborations highlight his commitment to advancing medical science.